|
QuantRx Biomedical Corporation is an emerging leader in the research and development of medical diagnostics, specializing in creating, acquiring and commercializing diagnostic platforms and developing products, based on its core intellectual property, for both professional and consumer use. The Company’s technology portfolio includes rapid point-of-care testing products that bring medical information directly to the healthcare provider or the patient; genome-based diagnostics chips for medical professionals and institutions, PAD technology for diagnosis and treatment of women’s health concerns and other medical needs, and diagnostic imaging products for the positron emission tomography (PET) market. QuantRx has corporate offices in Doylestown, Pennsylvania, and its research and development center in Portland, Oregon. Additionally, the company holds significant positions in FluoroPharma, Inc., a Boston-based molecular imaging company, and Genomics USA, Inc., a Chicago-based developer of microarray technology for DNA testing. For more information on QuantRx Biomedical Corporation, click company logo for Web site and Yahoo! Finance quote above.
| Recent Price: |
$0.70 |
|
Fiscal Year End: |
December 31 |
| 52-Week Price Range: |
$1.20–$0.43 |
|
Market Cap.: |
$29.2 million |
| Shares Out: |
41,699,681 |
|
Average Daily Volume: |
15,790 |
|
|
June 3, 2008:
May 20, 2008:
May 15, 2008:
April 10, 2008:
April 8, 2008:
March 12, 2008:
March 5, 2008:
March 3, 2008:
February 29, 2008:
February 21, 2008:
February 14, 2008:
January 29, 2008:
December 31, 2007:
November 13, 2007:
November 1, 2007:
October 25, 2007:
October 24, 2007:
October 24, 2007:
September 11, 2007:
September 4, 2007:
August 14, 2007:
July 31, 2007:
July 31, 2007:
July 31, 2007:
July 31, 2007:
July 6, 2007:
|
